Sabil Thottinakarayil

Sabil Thottinakarayil

Director Director DIN 02986938
DIN 02986938 First appointment May 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2010
Shareholding value •••• Premium profile

About Sabil Thottinakarayil

Data last updated:

Sabil Thottinakarayil was a Director at Xenocor Pharmalab Private Limited (2010–2022) and Director at Chiron Lifescience Private Limited (2017–2021). The companies operate in Pharma.

DIN 02986938
Primary Designation Director
Industry Pharma
First Appointment 01 May 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xenocor Pharmalab Private Limited U29299KA2007PTC042079
Director01 May 20102007₹8.98 Cr (FY 2024)Active
Chiron Lifescience Private Limited U24239KA2017PTC100834
Director23 Feb 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xenocor Pharmalab Private Limited
Chiron Lifescience Private Limited
Premium access

Shareholding and investment profile for Sabil Thottinakarayil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sabil Thottinakarayil

Sabil Thottinakarayil was first appointed on 01 May 2010 as Director at Xenocor Pharmalab Private Limited. The most recent appointment on record is 23 Feb 2017 at Chiron Lifescience Private Limited.

Sabil Thottinakarayil held 2 earlier board appointments: Xenocor Pharmalab Private Limited (Director, 01 May 2010 to 22 Mar 2022); Chiron Lifescience Private Limited (Director, 23 Feb 2017 to 19 Jan 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available